Litcius/Paper detail

<i>Babesia microti</i> Variant With Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone Prophylaxis

Nolan Holbrook, Erik H. Klontz, Gordon Adams, Samuel R Schnittman, Nicolas C. Issa, Sheila A. Bond, John A. Branda, Jacob E. Lemieux

2023Open Forum Infectious Diseases15 citationsDOIOpen Access PDF

Abstract

Abstract We report Babesia microti genomic sequences with multiple mutations in the atovaquone-target region of cytochrome b, including a newly identified Y272S mutation, plus 1 mutation of undetermined significance in the azithromycin-associated ribosomal protein L4. The parasite was sequenced from an immunocompromised patient on prophylactic atovaquone for Pneumocystis pneumonia before diagnosis of babesiosis.

Topics & Concepts

AtovaquoneVirologyAzithromycinMedicineBabesiosisMutationBabesiaParasite hostingBiologyMicrobiologyGeneticsGeneImmunologyMalariaPlasmodium falciparumAntibioticsComputer scienceWorld Wide WebVector-borne infectious diseasesPneumocystis jirovecii pneumonia detection and treatmentParasitic Infections and Diagnostics
<i>Babesia microti</i> Variant With Multiple Resistance Mutations Detected in an Immunocompromised Patient Receiving Atovaquone Prophylaxis | Litcius